During this segment, the panelists further discuss patient-centered care and explore the challenges that managed care stakeholders face as they attempt to establish new payment models that link reimbursement to measures of overall performance and outcomes of care.
As patient-centered care becomes the new standard, changes in the overall payment structure are expected to happen very quickly, explains Scott Gottlieb, MD. Although linking compensation to actual clinical care is a challenge, Dr Gottlieb and Brian Kiss, MD, suggest that patient-reported outcomes can be useful when establishing a new payment model.
Dr Kiss suggests that patient-reported outcomes (eg, adverse events) should be evaluated rather than patients’ functional statuses as determined by clinicians. Patient reports generally describe adverse events in much greater detail than physicians’ assessments do.
Government agencies should focus on assessing experiences and outcomes from the patients’ perspectives, adds Dr Gottlieb, as measuring what is happening in the clinical setting can be challenging.
Michael Kolodziej, MD, and Ted Okon, MBA, note that private payers are leading the way in payment reform. Mr Okon notes that while government programs are using antiquated systems incapable of bringing all the data together for use in evaluating quality, private payers are taking the lead in terms of combing data to evaluate outcomes.
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More